{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:28:51Z","timestamp":1761895731134,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.diabres.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T05:50:45Z","timestamp":1381384245000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Insulin detemir in the management of type 2 diabetes in non-Western countries: Safety and effectiveness data from the A1chieve observational study"],"prefix":"10.1016","volume":"101","author":[{"given":"Alexey","family":"Zilov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil El","family":"Naggar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunduo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihad","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.","key":"10.1016\/j.diabres.2013.06.003_bib0005","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.diabres.2013.06.003_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2013.06.003_bib0015","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2013.06.003_bib0020","first-page":"47","article-title":"Global Partnership for Effective Diabetes Management. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management","volume":"157","author":"Del Prato","year":"2007","journal-title":"Int J Clin Pract Suppl"},{"issue":"539","key":"10.1016\/j.diabres.2013.06.003_bib0025","first-page":"455","article-title":"Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study","volume":"57","author":"Calvert","year":"2007","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.diabres.2013.06.003_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1742-1241.2009.02002.x","volume":"63","author":"Valensi","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2013.06.003_bib0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diabres.2011.10.021","article-title":"An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study","volume":"94","author":"Home","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2013.06.003_bib0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1463-1326.2012.01602.x","article-title":"SOLVE Study Group. Study of Once Daily Levemir (SOLVE\u2122): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice","volume":"14","author":"Khunti","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2013.06.003_bib0045","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2013.06.003_bib0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1742-1241.2007.01309.x","article-title":"Why, when and how to initiate insulin therapy in patients with type 2 diabetes","volume":"61","author":"Tibaldi","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2013.06.003_bib0055","first-page":"26","article-title":"Insulin analog therapy: improving the match with physiologic insulin secretion","volume":"109","author":"Freeman","year":"2009","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.diabres.2013.06.003_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1185\/030079908X242755","article-title":"Improving glycemic control with insulin detemir using the 303 Algorithm in insulin na\u00efve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study","volume":"24","author":"Selam","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2013.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"doi-asserted-by":"crossref","unstructured":"Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care 2006;29:1269-74. Erratum in: Diabetes Care 2007;30:1035.","key":"10.1016\/j.diabres.2013.06.003_bib0070","DOI":"10.2337\/dc05-1365"},{"doi-asserted-by":"crossref","unstructured":"Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006;28:1569-81. Erratum in: Clin Ther 2006;28:1967.","key":"10.1016\/j.diabres.2013.06.003_bib0075","DOI":"10.1016\/j.clinthera.2006.10.020"},{"key":"10.1016\/j.diabres.2013.06.003_bib0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1463-1326.2009.01060.x","article-title":"TITRATE Study Group. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2013.06.003_bib0085","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1464-5491.2008.02483.x","article-title":"Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial","volume":"25","author":"Fajardo Monta\u00f1ana","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2013.06.003_bib0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-007-0911-x","article-title":"A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-na\u00efve people with type 2 diabetes","volume":"51","author":"Rosenstock","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2013.06.003_bib0095","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1463-1326.2006.00674.x","volume":"9","author":"Meneghini","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2013.06.003_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1742-1241.2008.01715.x","article-title":"PREDICTIVE Study Group. Insulin detemir improves glycaemic control without weight gain in insulinna\u00efve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study","volume":"62","author":"Dornhorst","year":"2008","journal-title":"Int J Clin Pract"},{"doi-asserted-by":"crossref","unstructured":"Shah SN, Litwak L, Haddad J, Chakkarwar PN, Hajjaji I. The A1chieve study: a 60000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice. Diabetes Res Clin Pract 2010; 88(Suppl 1):S11-6.","key":"10.1016\/j.diabres.2013.06.003_bib0105","DOI":"10.1016\/S0168-8227(10)70003-6"},{"key":"10.1016\/j.diabres.2013.06.003_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.diabres.2013.06.003_bib0115","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1463-1326.2007.00804.x","article-title":"The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes \u2013 results of the randomized, controlled PREDICTIVE 303 study","volume":"9","author":"Meneghini","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2013.06.003_bib0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1185\/03007990902840871","article-title":"PREDICTIVE Study Group. Once-daily insulin detemir in a cohort of insulin-na\u00efve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study","volume":"25","author":"Meneghini","year":"2009","journal-title":"Curr Med Res Opi"},{"key":"10.1016\/j.diabres.2013.06.003_bib0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.06.003_bib0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diacare.28.2.260","article-title":"INITIATE Study Group. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs","volume":"28","author":"Raskin","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.06.003_bib0135","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2008.11.001","article-title":"A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes","volume":"30","author":"Hollander","year":"2008","journal-title":"Clin Ther"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:05:30Z","timestamp":1759172730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822713002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0168822713002295"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2013.06.003","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin detemir in the management of type 2 diabetes in non-Western countries: Safety and effectiveness data from the A1chieve observational study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2013.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}